DSUR Submissions and Fees are Changing from 1 June 2024
The process for submitting Annual Safety Reports (ASRs) for Clinical Trials of Investigational Medicinal Products (CTIMP) to the MHRA is changing. From 01 June 2024, ASRs such as the Development Safety Update Report (DSUR) will not be considered valid unless … Continue reading DSUR Submissions and Fees are Changing from 1 June 2024
0 Comments
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
Related content and links
About the MHRA Inspectorate Blog
This blog shares the work of the Medicines and Healthcare products Regulatory Agency (MHRA) Inspectorate, by inspectors and those the Inspectorate works with.
Categories
Follow us on social media
Printing Posts
You can print blog posts using the keyboard shortcuts "Control P" or "Command P".